Smith MA - Search Results

1

McCarthy DJ, Alexander R, Smith MA, Pathak S, Kanes S, Lee CM, Sanacora G. McCarthy DJ, et al. Among authors: smith ma. Med Hypotheses. 2012 May;78(5):675-81. doi: 10.1016/j.mehy.2012.02.009. Epub 2012 Mar 4. Med Hypotheses. 2012. PMID: 22391030

2

The promise of rapidly acting antidepressants: challenges and opportunities.

Smith MA, Pathak S. Smith MA, et al. Biol Psychiatry. 2012 Aug 15;72(4):252-3. doi: 10.1016/j.biopsych.2012.05.033. Biol Psychiatry. 2012. PMID: 22840946 No abstract available.

3

Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.

Downey D, Dutta A, McKie S, Dawson GR, Dourish CT, Craig K, Smith MA, McCarthy DJ, Harmer CJ, Goodwin GM, Williams S, Deakin JF. Downey D, et al. Among authors: smith ma. Eur Neuropsychopharmacol. 2016 Jun;26(6):994-1003. doi: 10.1016/j.euroneuro.2016.03.006. Epub 2016 Apr 28. Eur Neuropsychopharmacol. 2016. PMID: 27133029 Clinical Trial.

4

Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective.

Wong EH, Yocca F, Smith MA, Lee CM. Wong EH, et al. Among authors: smith ma. Int J Neuropsychopharmacol. 2010 Oct;13(9):1269-84. doi: 10.1017/S1461145710000866. Epub 2010 Aug 18. Int J Neuropsychopharmacol. 2010. PMID: 20716397 Free article. Review.

5

The selective neurokinin 3 antagonist AZD2624 does not improve symptoms or cognition in schizophrenia: a proof-of-principle study.

Litman RE, Smith MA, Desai DG, Simpson T, Sweitzer D, Kanes SJ. Litman RE, et al. Among authors: smith ma. J Clin Psychopharmacol. 2014 Apr;34(2):199-204. doi: 10.1097/JCP.0000000000000071. J Clin Psychopharmacol. 2014. PMID: 24525659 Clinical Trial.

6

NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia.

Anticevic A, Gancsos M, Murray JD, Repovs G, Driesen NR, Ennis DJ, Niciu MJ, Morgan PT, Surti TS, Bloch MH, Ramani R, Smith MA, Wang XJ, Krystal JH, Corlett PR. Anticevic A, et al. Among authors: smith ma. Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16720-5. doi: 10.1073/pnas.1208494109. Epub 2012 Sep 25. Proc Natl Acad Sci U S A. 2012. PMID: 23012427 Free PMC article. Clinical Trial.

7

A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison.

Zhou D, Sunzel M, Ribadeneira MD, Smith MA, Desai D, Lin J, Grimm SW. Zhou D, et al. Among authors: smith ma. Br J Clin Pharmacol. 2012 Jul;74(1):98-108. doi: 10.1111/j.1365-2125.2011.04155.x. Br J Clin Pharmacol. 2012. PMID: 22122233 Free PMC article.

8

AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.

Litman RE, Smith MA, Doherty JJ, Cross A, Raines S, Gertsik L, Zukin SR. Litman RE, et al. Among authors: smith ma. Schizophr Res. 2016 Apr;172(1-3):152-7. doi: 10.1016/j.schres.2016.02.001. Epub 2016 Feb 26. Schizophr Res. 2016. PMID: 26922656 Clinical Trial.

9

Rapid dose escalation with quetiapine: a pilot study.

Smith MA, McCoy R, Hamer-Maansson J, Brecher M. Smith MA, et al. J Clin Psychopharmacol. 2005 Aug;25(4):331-5. doi: 10.1097/01.jcp.0000168486.14516.7c. J Clin Psychopharmacol. 2005. PMID: 16012275 Clinical Trial.

10

Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia.

Wolf DH, Zheng D, Kohler C, Turetsky BI, Ruparel K, Satterthwaite TD, Elliott MA, March ME, Cross AJ, Smith MA, Zukin SR, Gur RC, Gur RE. Wolf DH, et al. Among authors: smith ma. Mol Psychiatry. 2022 Feb;27(2):1226-1232. doi: 10.1038/s41380-021-01320-w. Epub 2021 Oct 20. Mol Psychiatry. 2022. PMID: 34667261 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,100 results

Search Page